Podcast CME Course Information
Exam: Exam 352
Issue: May 16, 2017
Risks and benefits of clopidogrel–aspirin in minor stroke or TIA: Time course analysis of CHANCE
Upon completion of this podcast, listeners will learn about the risks and benefits of dual antiplatelet therapy in patients with minor stroke and TIA.
This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.
- Patient Care
- Medical Knowledge
Program Accreditations Subcommittee (PAS) is responsible for reviewing and evaluating all CME programs. Joseph F. Kass, MD, JD, FAAN, has received personal compensation for activities as an expert witness in litigation and in an editorial capacity for the American Academy of Neurology. Barney J. Stern, MD, FAAN, has received personal compensation for book chapter contributions. The other members of the committee (Samir Belagaje, MD; J. Clay Goodman, MD, FAAN; Omotola A. Hope, MD; Shannon M. Kilgore, MD, FAAN) and AAN staff (Kristine Mitchell) report no disclosures. Robert A. Gross, MD, PhD, FAAN, has received funding for travel and/or speaker honoraria from the American Academy of Neurology; receives a stipend as Editor-in-Chief of Neurology; has received consultant fees from GlaxoSmithKline and Harris Interactive; has served on speakers' bureaus for Abbott, UCB, and GlaxoSmithKline; has conducted clinical trials over the past 5 years funded by GlaxoSmithKline, UCB, Ortho-McNeil, Pfizer, and Marinus, but has ceased participation in industry-sponsored clinical trials and speakers' bureaus since his appointment as Neurology EIC in 2010; and has received research support from the Department of the Army, UCBPharma, and University of Rochester Medical Center/NIH. Dr. Ted Burns serves as Podcast Editor for Neurology® and has received research support for consulting activities with UCB, CSL Behring, Walgreens and Alexion Pharmaceuticals, Inc. Dr. Andrew Southerland serves as Podcast Deputy Editor for Neurology; and serves as Clinical Research Advisor for Totier Technologies, Inc. AAN staff members editing the test (P Baskin, L Kleffman, K Aman Ramm) have no disclosures. The CME Journal Editors who have reviewed the exam are James WM Owens Jr., MD PhD, who receives royalties from UpToDate, Waltham, MA; grant support from NIH (PI, K08NS054882); and a stipend in his editorial capacity for Neurology and Adam Kelly, MD, who has served as Guest Editor of Continuum (April 2014) and receives a stipend in his editorial capacity for Neurology.
Dr. Wang receives research support from the Ministry of Science and Technology of the People’s Republic of China (No. 2011BAI08B02) and the National Natural Science Foundation of China (No. 81322019). Dr. Mauermann serves on the editorial board for Mayo Clinic Proceedings; receives publishing royalties from Autonomic Neurology (Oxford 2015); and receives research support from Ionis Pharmaceuticals, Inc., and Alnylam Pharmaceauticals.
The other participants report no disclosures.
CME expires three years after publication date or sooner if podcasts are deemed out of date by reviewers.
The American Academy of Neurology Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA PRA Credit™
The American Academy of Neurology Institute designates this journal-based-CME activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Academy of Neurology holds copyright for all materials in this exam.
Any information regarding the identity of individuals taking the exam or their exam scores will be kept confidential.
Hardware and Software Requirements
A computer with a web browser such as Internet Explorer, Firefox, Safari, or Google Chrome is required.
For More Information
Executive Editor, Neurology®